Dong, Siqi, Meng Wang, Ziyan Luo, Weizhe Wu, Haiying Huang, Jianping Yang, Yufeng Liang, Hua Jiang, and Lin Qiu. 2020. “Glofitamab Plus Polatuzumab Vedotin: a Novel Safe, and Highly Effective Chemotherapy-Free Regimen for Pediatric relapsed/Refractory B-Cell Non-Hodgkin Lymphoma”. Haematologica, September. Pavia, Italy. https://doi.org/10.3324/haematol.2026.300836.